ACE-031 (Activin Type 2B) – 1MG per vial

Clinical Test Expectation ACE-031 - Human Subjects : Massive increases in muscle mass and strength Strength - 1MG per vial

Introduction ACE-031 is a soluble form of activin receptor type IIB (ActRIIB). ACE-031 promotes muscle growth by binding to myostatin and other negative regulators of muscle mass.

The scientists are still figuring out what properties the peptide has , but we already know a number of beneficial effects of its use, including:

• acceleration of muscle gain process by blocking myostatin hormone;
• fat-burning effect. ACE-031 reduces the amount of leptin and thus increases the adiponectin level;
• improves the density of bones, thus making them more durable and less prone to fractures and other injuries;
• no side effects. The peptide is absolutely safe, when administered at dosages that do not exceed the norm, ACE-031 does not have any side effects. Very rarely there may be headaches and discomfort at the injection site.

Dosing Details You inject 1.1ml water into the vial of ACE031 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 5 (half a unit) on the syringe each day in the morning and inject it into the muscle (Intra Muscular) at site of growth bilaterally (that is 2.5 into each side totaling 5) directly into muscle. Alternative for easier use :You inject 2.1ml water into the vial of ACE031 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 10 (1 unit) on the syringe each day in the morning and inject it into the muscle (Intra Muscular) at site of growth bilaterally (that is 5 into each side totaling 10) Directly into muscle.

How long will a vial last ? A vial should last 10 days.

Clinical Test Expectation Gonadorelin - Human Subjects : In males - Delayed puberty. Infertility in males caused by pituitary or hypothalamus problems. In females - cause ovulation (release of an egg from the ovary) in women who do not have regular ovulation and menstrual periods Strength - 5MG per vial

Introduction Gonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pituitary.

Dosing Details : You inject 2ml water into the vial of Gonadorelin from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 20 (2 units) on the syringe each morning before breakfast and inject it into the tummy under the skin into the fatty skin layer.

How long will a vial last ? A vial should last 7 days

Clinical Test Expectation Adipotide - Human Subjects : Faster muscle mass growth, superior fat-burning power Strength - 5MG per vial

Introduction Adipotide is a synthetic peptide that possesses anti-obesity properties. this peptide particularly targets and destroys specific proteins that constitute the surface of blood vessels that support white fat (adipose) tissue hence interfering with the supply of blood to the fat cells and resulting in their adoptosis (reabsorption and metabolization). Adipotide was initially referred to as Prohibitin-TP01 (Prohibitin-Targeting Peptide 1). It is a peptidomimetic that was synthesized by American scientists as a potential therapeutic drug for obesity and its amino acid sequence is CKGGRAKDC-GG-D(KLAKLAK)2. Adipotide has a molecular formula of C111H204N36O28S2. Peptidomimetics are tiny protein like chains that imitate peptides. It is an experimental drug for weight loss. It was developed in a way that enables it to bind to two receptors, prohibitin and ANXA2 which are found in blood vessels that support white adipose tissue. In rat and monkey based experiments, Adipotide has been shown to bring about rapid weight loss in both mice and rhesus monkeys. In general, Adipotide has been observed to bring about weight loss by reducing fat tissue especially in the abdominal region), rapid metabolic changes, and decreased food intake.

Dosing Details ADIPOTIDE – Week 1 : You inject 2ml water into the vial of Adipotide from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 15 (one and a half units) on the syringe each morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 14 days. ADIPOTIDE – Week 2 to 4 :You inject 2ml water into the vial of Adipotide from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 30 (3 units) on the syringe each morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 7 days. Alternative Salon usage : You inject 4ml water into the vial of Adipotide from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 60 (6 units) on the syringe and inject 15 (one quarter of drawn amount) into each corner of the areas you want to be affected, for client. A vial should last 7 days.

How long will a vial last ? A vial should last 7 to 14 days

Clinical Test Expectation GHK-cu - Human Subjects : Wound healing and antiaging skin care ++. Antioxidant and Anti-Inflammatory Properties. Stimulates Blood Vessel Growth. Increases Neurotrophins. Gene Regulator. Reverse Gene Silencing Strength - 100MG per vial

Introduction The human peptide GHK-cu (glycyl-l-histidyl-l-lysine) has multiple biological actions, all of which, according to our current knowledge, appear to be health positive. It stimulates blood vessel and nerve outgrowth, increases collagen, elastin, and glycosaminoglycan synthesis, as well as supports the function of dermal fibroblasts. GHK’s ability to improve tissue repair has been demonstrated for skin, lung connective tissue, boney tissue, liver, and stomach lining. GHK has also been found to possess powerful cell protective actions, such as multiple anti-cancer activities and anti-inflammatory actions, lung protection and restoration of chronic obstructive pulmonary disease (COPD) fibroblasts, suppression of molecules thought to accelerate the diseases of aging such as NFκB, anti-anxiety, anti-pain and anti-aggression activities, DNA repair, and activation of cell cleansing via the proteasome system. Recent genetic data may explain such diverse protective and healing actions of one molecule, revealing multiple biochemical pathways regulated by GHK.

Dosing Details You inject 2ml water into the vial of GHK cu from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear blue in colour you draw out 20 (2 units) on the syringe each morning before breakfast and inject it into the tummy under the skin into the fatty skin layer.

How long will a vial last ? A vial should last 10 days.

Clinical Test Expectation - Tirzepatide - Human Subjects : Aids type 2 diabetis. Assist with large scale weight loss. Strength - 2MG per vial

Introduction Historically, the treatment of obesity focused almost exclusively on lifestyle-based approaches. However, evidence that diet and exercise prompt physiological counterregulatory mechanisms that limit weight reduction and impede weight maintenance has led to the realization that obesity is a complex, multicomponent metabolic disease of energy homeostasis involving central and peripheral mechanisms. Once obesity is present, those mechanisms render a return to lower weight difficult. Accordingly, several clinical guidelines now recommend treatment with antiobesity medications for people with obesity or for those with overweight and weight-related complications. Recent studies with long-acting glucagon-like peptide-1 (GLP-1) receptor agonists demonstrated that greater efficacy with acceptable safety could be achieved by targeting the pathways of endogenous nutrient-stimulated hormones. Glucose-dependent insulinotropic polypeptide (GIP), another nutrient-stimulated hormone, regulates energy balance through cell-surface receptor signaling in the brain and adipose tissue. A molecule that combines both GIP and GLP receptor agonism theoretically may lead to greater efficacy in weight reduction.

Tirzepatide is a once-weekly subcutaneous injectable peptide (approved by the Food and Drug Administration [FDA] for type 2 diabetes) engineered from the native GIP sequence, with agonist activity at both the GIP and GLP-1 receptors. Preclinical data demonstrated that the affinity of tirzepatide for GIP receptors was equal to the affinity of native GIP for GIP receptors, whereas tirzepatide bound GLP-1 receptors with affinity approximately five times weaker than native GLP-1 bound GLP-1 receptors. GIP activation appeared to act synergistically with GLP-1 receptor activation to allow greater weight reduction in humans than that achieved with GLP-1 receptor monoagonism. In phase 2 studies in people with type 2 diabetes, tirzepatide induced clinically relevant weight reduction, warranting further investigation for the treatment of obesity. The present trial, SURMOUNT-1, evaluated the efficacy and safety of tirzepatide in adults with obesity or overweight who did not have diabetes with great success

Dosing Details You inject 1ml water into the vial of Tirzepatide from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out the entire vial and inject it into the tummy under the skin into the fatty skin layer. A vial should last 1 usage once a week.

How long will a vial last ? A vial should last 7 days.

Clinical Test Expectation GHRP-2 - Human Subjects : Stimulation of GH secretion. Appetite promotion. Fat mass decrease. Lowering of cholesterol level. Skin and bones state improvement. Defence of the liver and anti-inflammatory action. Aid flexibility and joint health. Promotes better recovery from injuries and training. Improve sleep. Enhanced Anti-aging benefits. Accelerates growth of muscle tissue and reduces body fat. Promotes significant increase in strength and endurance. Strength - 10MG per vial

Introduction Growth Hormone Releasing Peptide-2 (GHRP-2), also known as Pralmorelin, is a synthetically made growth hormone secretagogue, a peptide that stimulates the body to increase natural production of growth hormone. GHRP-2 is an agonist of ghrelin, a gut peptide and also known as “the hunger hormone”, which binds to the growth hormone secretagogue receptor. Ghrelin has been shown to stimulate growth hormone secretion and appetite initiation. 

GHRP-2 is used to increase muscle mass, decrease body fat, and enhance flexibility and joint health. GHRP-2 also promotes better recovery from injuries and training. GHRP-2 is also functions to improve sleep, enhance anti-aging benefits, and improved overall health and wellness. Higher growth hormone levels also lead to greater production of IGF-1 in the body, which improves in lean body composition, accelerates growth of muscle tissue and reduces body fat. GHRP-2 promotes significant increase in strength and endurance, especially when used long term. Athletic performance, physical capacity, and aging-related decline all have the ability to improve drastically with the use of this peptide.

GHRP-2 is widely regarded as one of the most effective growth hormone releasing peptides for both athletic performance and anti-aging effects. It promotes substantial increases in the body’s output of growth hormone while minimizing the powerful hunger side effects associated with GHRP-6. This may lead to significant improvements in lean body composition.

GHRP-2 works to enhance natural growth hormone production in two ways. First, the GHRP-2 intensifies the natural growth hormone releasing signal, resulting in a substantial secretion of growth hormone. Second, it suppresses a hormone in the body called somatostatin, also known as growth hormone inhibiting hormone (GHIH). Somatostatin generates the body to decrease its natural growth hormone production. By restricting the activity of somatostatin, GHRP-2 can improve growth hormone creation, resulting in increased natural growth hormone levels. GHRP-2 also activates ghrelin, a peptide hormone produced in the gastrointestinal system, which has strong effects on growth hormone production and appetite.

As GHRP-2 stimulates the body to create growth hormone, there is no shutdown of natural growth hormone production as occurs with synthetic hGH administration. GHRP-2 causes growth hormone secretion in a manner that firmly resembles natural release patterns, instead of being continually raised. This method prevents many of the negative side effects of synthetic hGH administration, including the shutdown of natural growth hormone production.

Dosing Details

How long will a vial last ? A vial should last 10 days